Expression of nitric oxide synthases and endogenous NO metabolism in bronchopulmonary dysplasia

Pediatric Pulmonology

Volumn 43, Issue 7, 2008, Pages 703-709

  Davis, Christiana W ^a   Gonzales, Linda W ^a   Ballard, Roberta A ^a   Ballard, Philip L ^a   Guo, Changjiang ^b   Gow, Andrew J ^b,c  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

Bronchopulmonary dysplasia; Chronic lung disease; Inflammation; Nitrotyrosine; S nitrosothiol

Indexed keywords

3 NITROTYROSINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; S NITROSOTHIOL;

ARTICLE; AUTOPSY; CAUSE OF DEATH; CHRONIC LUNG DISEASE; CHYLOTHORAX; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LOCALIZATION; EPITHELIUM CELL; FLUORESCENCE MICROSCOPE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFANT; INFLAMMATION; LUNG ALVEOLUS PROTEINOSIS; LUNG BIOPSY; LUNG DYSPLASIA; LUNG TRANSPLANTATION; METABOLITE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BIOLOGICAL MARKERS; BRONCHOPULMONARY DYSPLASIA; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; KERATINS; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

EID: 46849121401     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.20848     Document Type: Article

References (33)

1. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;163:1723-1729.
2. Northway WH Jr, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med 1967;276:357-368.
3. Jobe AH. Antenatal factors and the development of bronchopulmonary dysplasia. Semin Neonatol 2003;8:9-17.
4. Ventura SJ, Martin JA, Curtin SC, Mathews TJ. Report of final nationality statistics, 1996. Mon Vital Stat Rep 1998;46:1-99.
5. Parker RA, Lindstrom DP, Cotton RB. Evidence from twin study implies possible genetic susceptibility to bronchopulmonary dysplasia. Semin Perinatol 1996;20:206-209.
6. Jobe AJ. The new BPD: an arrest of lung development. Pediatr Res 1999;46:641-643.
7. Coalson JJ, Winter VT, Siler-Khodr T, Yoder BA. Neonatal chronic lung disease in extremely immature baboons. Am J Respir Crit Care Med 1999;160:1333-1346.
8. Murad F. The 1996 Albert Lasker Medical Research Awards. Signal transduction using nitric oxide and cyclic guanosine monophosphate. JAMA 1996;276:1189-1192.
9. Schmidt HHHW, Walter U. NO at work. Cell 1994;78:919-925.
10. Barnes PJ. Nitric oxide and airway disease. Ann Med 1995;27:389-393.
11. Ricciardolo FLM, Sterk PJ, Gaston B, Folkerts G. Nitric oxide in health and disease of the respiratory system. Physiol Rev 2004;84:731-765.
12. Nijkamp FP, Folkerts G. Nitric oxide and bronchial hyperresponsiveness. Arch Int Pharmacodyn Ther 1995;329:81-96.
13. Afshar S, Gibson LL, Yuhanna IS, Sherman TS, Kerecman JD, Grubb PH, Yoder BA, McCurnin DC, Shaul PW. Pulmonary NO synthase expression is attenuated in a fetal baboon model of chronic lung disease. Am J Physiol Lung Cell Mol Physiol 2003;284:L749-L758.
14. Banks BA, Ischiropoulos H, McClelland M, Ballard PL, Ballard RA. Plasma 3-nitrotyrosine is elevated in premature infants who develop bronchopulmonary dysplasia. Pediatrics 1998;101:870-874.
15. Farkouh CR, Merrill JD, Ballard PL, Ballard RA, Ischiropoulos H, Lorch SA. Urinary metabolites of oxidative stress and nitric oxide in preterm and term infants. Biol Neonate 2006;90:233-242.
16. Gow AJ, Davis CW, Munson D, Ischiropoulos H. Immunohistochemical detection of 5-nitrosylated proteins. Methods Mol Biol 2004;279:167-172.
17. Gow AJ, Chen Q, Hess DT, Day BJ, Ischiropoulos H, Stamler JS. Basal and stimulated protein 5-nitrosylation in multiple cell types and tissues. J Biol Chem 2002;277:9637-9640.
18. Kobzik L, Bredt DS, Lowenstein CJ, Drazen J, Gaston B, Sugarbaker D, Stamler JS. Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization. Am J Respir Cell Mol Biol 1993;9:371-377.
19. Hamid Q, Springall DR, Riveros-Moreno V, Chanez P, Howarth P, Redington A, Bousquet J, Godard P, Holgate S, Polak JM. Induction of nitric oxide synthase in asthma. Lancet 1993;342:1510-1513.
20. Guo FH, Raeve HRD, Rice TW, Stuehr DJ, Thunnissen F, Erzurum SC. Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo. Proc Natl Acad Sci 1995;92:7809-7813.
21. Chiba Y, Arimoto T, Yoshikawa T, Misawa M. Elevated nitric oxide synthase activity concurrent with antigen-induced airway hyperresponsiveness in rats. Exp Lung Res 2000;26:535-549.
22. Haddad EB, Liu SF, Salmon M, Robichaud A, Barnes PJ, Chung KF. Expression of inducible nitric oxide synthase mRNA in Brown Norway rats exposed to ozone: effect of dexamethasone. Eur J Pharmacol 1995;293:287-290.
23. Ischiropoulos H. Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species. Arch Biochem Biophys 1998;356:1-11.
24. Ischiropoulos H, Zhu L, Chen J, Tsai M, Martin JC, Smith CD, Beckman JS. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch Biochem Biophys 1992;298:431-437.
25. Stamler JS, Lamas S, Fang FC. Nitrosylation. the prototypic redox-based signaling mechanism. Cell 2001;106:675-683.
26. Nelson EJ, Connolly J, McArthur P. Nitric oxide and S- nitrosylation: excitotoxic and cell signaling mechanism. Biol Cell 2003;95:3-8.
27. Andreadis AA, Hazen SL, Comhair SA, Erzurum SC. Oxidative and nitrosative events in asthma. Free Radic Biol Med 2003;35:213-225.
28. Lamb NJ, Gutteridge JM, Baker C, Evans TW, Quinlan GJ. Oxidative damage to proteins of bronchoalveolar lavage fluid in patients with acute respiratory distress syndrome: evidence for neutrophil-mediated hydroxylation, nitration, and chlorination. Crit Care Med 1999;27:1738-1744.
29. Morrissey BM, Schilling K, Weil JV, Silkoff PE, Rodman DM. Nitric oxide and protein nitration in the cystic fibrosis airway. Arch Biochem Biophys 2002;406:33-39.
30. Dugas B, Kolb JP. Nitric oxide production in human inflammatory processes. Res Immunol 1995;146:661-663.
31. Eiserich JP, Hristova M, Cross CE, Jones AD, Freeman BA, Halliwell B, van der Vliet A. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 1998;391:393-397.
32. Auten RL, Mason SN, Whorton MH, Lampe WR, Foster WM, Goldberg RN, Li B, Stamler JS, Auten KM. Inhaled ethyl nitrite prevents hyperoxia-impaired postnatal alveolar development in newborn rats. Am J Respir Crit Care Med 2007;176:291-299.
33. Ballard RA, Truog WE, Cnaan A, Martin RJ, Ballard PL, Merrill JD, Walsh MC, Durand DJ, Mayock DE, Eichenwald EC, Null DR, Hudak ML, Puri AR, Golombek SG, Courtney SE, Stewart DL, Welty SE, Phibbs RH, Hibbs AM, Luan X, Wadlinger SR, Asselin JM, Coburn CE, the NOCLDSG. Inhaled nitric oxide in preterm infants undergoing mechanical ventilation. N Engl J Med 2006;355:343-353.